138 related articles for article (PubMed ID: 3528862)
1. Analysis of T-cell subsets in rejection of Kb mutant skin allografts differing at class I MHC.
Rosenberg AS; Mizuochi T; Singer A
Nature; 1986 Aug 28-Sep 3; 322(6082):829-31. PubMed ID: 3528862
[TBL] [Abstract][Full Text] [Related]
2. Evidence for involvement of dual-function T cells in rejection of MHC class I disparate skin grafts. Assessment of MHC class I alloantigens as in vivo helper determinants.
Rosenberg AS; Mizuochi T; Singer A
J Exp Med; 1988 Jul; 168(1):33-45. PubMed ID: 2456372
[TBL] [Abstract][Full Text] [Related]
3. Frequency analysis of class I MHC-reactive Lyt-2+ and class II MHC-reactive L3T4+ IL 2-secreting T lymphocytes.
Heeg K; Steeg C; Schmitt J; Wagner H
J Immunol; 1987 Jun; 138(12):4121-7. PubMed ID: 3108383
[TBL] [Abstract][Full Text] [Related]
4. T-lymphocyte subsets: major histocompatibility antigens rejection of H-2K or H-2I region disparate skin allografts by either Lyt-2+ or L3T4+ T-lymphocyte subset.
Smith DM; McKisic M; Stuart FP; Fitch FW
Transplant Proc; 1989 Feb; 21(1 Pt 1):162-4. PubMed ID: 2650100
[No Abstract] [Full Text] [Related]
5. Specific prolongation of MHC class II disparate skin allografts by in vivo administration of anti-IFN-gamma monoclonal antibody.
Rosenberg AS; Finbloom DS; Maniero TG; Van der Meide PH; Singer A
J Immunol; 1990 Jun; 144(12):4648-50. PubMed ID: 2112572
[TBL] [Abstract][Full Text] [Related]
6. Induced expression of class II major histocompatibility complex antigens on thyroid but not pancreatic islet allografts following transfer of sensitized LYT2+ T cells.
Warren HS; Simeonovic CJ; Allan W; Hume DA
Transplant Proc; 1987 Feb; 19(1 Pt 1):213. PubMed ID: 3152690
[No Abstract] [Full Text] [Related]
7. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts.
Dalloul AH; Chmouzis E; Ngo K; Fung-Leung WP
J Immunol; 1996 Jun; 156(11):4114-9. PubMed ID: 8666777
[TBL] [Abstract][Full Text] [Related]
8. IL-5 mediates eosinophilic rejection of MHC class II-disparate skin allografts in mice.
Le Moine A; Surquin M; Demoor FX; Noël JC; Nahori MA; Pretolani M; Flamand V; Braun MY; Goldman M; Abramowicz D
J Immunol; 1999 Oct; 163(7):3778-84. PubMed ID: 10490975
[TBL] [Abstract][Full Text] [Related]
9. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
[TBL] [Abstract][Full Text] [Related]
10. Cellular pathways for rejection of class-I-MHC--disparate skin and tumor allografts.
Smith DM; Stuart FP; Wemhoff GA; Quintáns J; Fitch FW
Transplantation; 1988 Jan; 45(1):168-75. PubMed ID: 3276046
[TBL] [Abstract][Full Text] [Related]
11. Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection.
Rosenberg AS; Mizuochi T; Sharrow SO; Singer A
J Exp Med; 1987 May; 165(5):1296-315. PubMed ID: 2437237
[TBL] [Abstract][Full Text] [Related]
12. Characterization of primary T cell subsets mediating rejection of pancreatic islet grafts.
Gill RG; Rosenberg AS; Lafferty KJ; Singer A
J Immunol; 1989 Oct; 143(7):2176-8. PubMed ID: 2506278
[TBL] [Abstract][Full Text] [Related]
13. Vulnerability of allografts to rejection by MHC class II-restricted T-cell receptor transgenic mice.
Lee MK; Huang X; Jarrett BP; Moore DJ; Desai NM; Moh Lian M; Markmann JW; Deng S; Frank A; Singer A; Velidedeoglu E; Caton AJ; Markmann AJ
Transplantation; 2003 Apr; 75(8):1415-22. PubMed ID: 12717241
[TBL] [Abstract][Full Text] [Related]
14. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition.
Sano Y; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1422-31. PubMed ID: 10798658
[TBL] [Abstract][Full Text] [Related]
15. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.
Chen PW; Ananthaswamy HN
J Immunol; 1993 Jul; 151(1):244-55. PubMed ID: 8326126
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Abeta(b-/-), H2-DM(-), and CIITA(-/-) in second-set skin allograft rejection.
Felix NJ; de Serres S; Meyer AA; Ting JP
J Surg Res; 2002 Feb; 102(2):185-92. PubMed ID: 11796017
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of rejection of MHC class I-disparate murine skin grafts. III. Are L3T4+ T cells involved in the rejection?
Kobayashi E; Kawai K; Ikarashi Y; Watanabe H; Ito M; Fujiwara M
Transplant Proc; 1991 Jun; 23(3):2008-11. PubMed ID: 1676551
[No Abstract] [Full Text] [Related]
18. Immune mechanisms of tissue destruction in vivo.
Singer A; Rosenberg AS
Princess Takamatsu Symp; 1988; 19():209-14. PubMed ID: 2908354
[TBL] [Abstract][Full Text] [Related]
19. L3T4+ T-cell-independent reactivity of Lyt2+ T cells in vivo.
Heeg K; Steeg C; Wagner H
Cell Immunol; 1988 Jan; 111(1):148-57. PubMed ID: 2962740
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets.
Raziuddin A; Longo DL; Mason L; Ortaldo JR; Bennett M; Murphy WJ
J Immunol; 1998 Jan; 160(1):87-94. PubMed ID: 9551959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
